Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit

Southern African Journal of Infectious Diseases

 
 
Field Value
 
Title Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
 
Creator Abrahams, Ilhaam Dramowski, Angela Moloto, Kedisaletse Lloyd, Lizel Whitelaw, Andrew Bekker, Adrie
 
Subject carbapenem-resistant Enterobacterales; colistin therapy, colistin-related adverse effects Carbapenem-resistant Enterobacterales; antibiotic resistance; neonate; colistin; safety
Description Background: Colistin is increasingly prescribed for neonates with carbapenem-resistant Enterobacterales (CRE) infections.Objectives: We described patient demographics, infection episodes, treatment and clinical outcomes, colistin related adverse events and relatedness of isolates in neonates with clinically confirmed or clinically suspected CRE infections.Method: The authors retrospectively reviewed culture-confirmed and clinically suspected culture-negative CRE infections at a South African neonatal unit during a CRE outbreak.Results: Fifty-three neonates (median gestational age 29 weeks and birth weight 1185 g) were included. Twenty-three of 53 neonates (43%) had culture-confirmed CRE (17 received colistin; 6 died without receiving colistin) and 30 (57%) received colistin for clinically suspected CRE infection but were ultimately culture-negative. Prior respiratory support and surgical conditions were present in 37/53 (70%) and 19/53 (36%) neonates, respectively. Crude mortality was high (20/53; 38%) with no significant difference between culture-confirmed CRE versus clinically suspected culture-negative CRE groups (10/23 [44%] vs 10/30 [33%]; p = 0.45). Hypomagnesaemia (10/38; 26%) and hypokalaemia (15/38; 40%) were frequent; acute kidney injury was rare (1/44; 2%). Three CRE infection clusters were identified by genotypic analysis of 20 available isolates (18 [90%] blaNDM-1 [New Delhi metallo-beta-lactamase], 2 [10%] blaOXA [oxacillinase]-48).Conclusion: Neonates receiving colistin therapy were predominantly preterm, with multiple risk factors for infection. Colistin-associated electrolyte derangement was frequent. Over one-third of neonates died. BlaNDM-1 was the most frequent carbapenemase gene identified in the outbreak isolates.Contribution: Colistin was safely used during an Enterobacterales outbreak in predominantly premature and surgical neonates. The mortality was high.
 
Publisher AOSIS Publishing
 
Contributor Stellenbosch University division of Paediatrics and Child Health, Medical Microbiology, and National Health Laboratory Service
Date 2023-01-30
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Descriptive
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajid.v38i1.487
 
Source Southern African Journal of Infectious Diseases; Vol 38, No 1 (2023); 8 pages 2313-1810 2312-0053
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajid.co.za/index.php/sajid/article/view/487/1158 https://sajid.co.za/index.php/sajid/article/view/487/1159 https://sajid.co.za/index.php/sajid/article/view/487/1160 https://sajid.co.za/index.php/sajid/article/view/487/1161
 
Coverage tertiary hospital; neonatal unit — —
Rights Copyright (c) 2023 Ilhaam Abrahams, Angela Dramowski, Kedisaletse Moloto, Lizel Lloyd, Andrew Whitelaw, Adrie Bekker https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT